ID   Huh-7.5 STAT1 KO #2
AC   CVCL_C2UX
DR   cancercelllines; CVCL_C2UX
DR   Wikidata; Q114311676
RX   PubMed=27929099;
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 11362; STAT1.
CC   Sequence variation: Mutation; HGNC; 6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 19102; RIGI; Simple; p.Thr55Ile (c.164C>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7927 ! Huh-7.5
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 5
//
RX   PubMed=27929099; DOI=10.1038/srep38336;
RA   Yamauchi S., Takeuchi K., Chihara K., Honjoh C., Kato Y., Yoshiki H.,
RA   Hotta H., Sada K.;
RT   "STAT1 is essential for the inhibition of hepatitis C virus
RT   replication by interferon-lambda but not by interferon-alpha.";
RL   Sci. Rep. 6:38336-38336(2016).
//